...
首页> 外文期刊>Biochimica et biophysica acta: international journal of biochemistry and biophysics >Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
【24h】

Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.

机译:李斯特菌溶血素O脂质体介导的大分子抗原在体内的胞质递送:增强抗原特异性细胞毒性T淋巴细胞的频率,活性和肿瘤保护作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cytotoxic T lymphocytes (CTLs) are primed by peptide antigens that are endogenously processed in the cytosol and presented in the context of major histocompatibility complex I (MHC I) molecules of antigen-presenting cells (APCs). Exogenous soluble protein antigens do not gain efficient entry into the cytosol of APCs, and therefore requires a special cytosolic delivery method. We have developed such a delivery strategy adopting the well-elucidated cytosol-invading listerial endosomal escape mechanism, and report here an efficient delivery of exogenous whole protein antigen into the cytosol in a mouse model. Co-encapsulation of listeriolysin O (LLO) inside liposome (LLO-liposome) was required for delivery of ovalbumin (OVA) into the cytosol of APCs in primary cultures. LLO-liposome-mediated OVA immunization in mice engendered significantly higher OVA-specific CTL activity and increased antigenic peptide-specific CTL precursor (CTLp) frequency as compared to non-LLO-liposome or soluble OVA immunizations. Interferon-gamma (IFN-gamma) production upon specific stimulation by MHC I-restricted peptide was also significantly stronger by the inclusion of LLO in the liposomes. Rerouting of antigen into the cytosol by LLO-liposomes, however, did not reduce the extent of anti-OVA antibody responses. Moreover, LLO-liposome-antigen vaccination was robust in conferring protection to mice from lethal challenges with antigen-expressing tumor cells. Our study demonstrates a novel delivery system for efficient introduction of exogenous protein into the cytosol in vivo, priming cellular immune responses, which are protective in nature.
机译:细胞毒性T淋巴细胞(CTL)由在细胞质中内源加工的肽抗原引发,并在抗原呈递细胞(APC)的主要组织相容性复合物I(MHC I)分子的背景下呈递。外源可溶性蛋白抗原不能有效地进入APC的胞质溶胶,因此需要特殊的胞质递送方法。我们已经开发出了一种采用充分阐明的侵入胞质的利斯特菌内体逃逸机制的递送策略,并在此报告了将外源全蛋白抗原有效递送到小鼠模型的胞质中。脂质体(LLO-脂质体)内部的李斯特菌溶血素O(LLO)的共包封是将卵清蛋白(OVA)递送到原代培养的APC胞质中所必需的。与非LLO-脂质体或可溶性OVA免疫相比,小鼠中的LLO-脂质体介导的OVA免疫可显着提高OVA特异性CTL活性,并增加抗原肽特异性CTL前体(CTLp)频率。通过在脂质体中包含LLO,受MHC I限制性肽特异性刺激后,干扰素-γ(IFN-γ)的产生也明显增强。然而,通过LLO-脂质体将抗原重新路由到细胞质中并没有降低抗OVA抗体反应的程度。此外,LLO-脂质体-抗原疫苗接种在向小鼠提供保护方面使其免受表达抗原的肿瘤细胞的致命攻击。我们的研究证明了一种新颖的递送系统,可将外源蛋白有效地引入体内细胞质,引发细胞免疫反应,这是自然保护性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号